Interaction of serine proteases from polymorphonuclear leucocytes with the cell surface and heparin.
Polymorphonuclear leucocytes (PMNs) accumulate at inflammatory sites and contribute to host defence, regulation of the inflammatory process, and also to tissue injury. Upon activation, these cells release the serine proteases elastase, cathepsin G, and proteinase 3 that are involved in multiple processes such as microbicidal activity, penetration of PMNs through endothelium and adjacent connective tissue to inflammatory sites, and processing of various cytokines. Here, we compared the three serine proteases for their release from PMNs and their ability to interact with resting PMNs and the highly sulphated glycosaminoglycan heparin. Unlike elastase, proteinase 3 and cathepsin G were released from resting PMNs as evidenced by flow cytometry, confocal fluorescence microscopy, and activity measurements. While proteinase 3 binds heavily to surface targets on vital PMNs, cathepsin G and elastase interact preferentially with sulphated glycosaminoglycans. These data revealed a differentiated picture about the individual functions of the PMN serine proteases during inflammatory response.
Institute for Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Härtelstrasse 16-18, 04107, Leipzig, Germany.
Jana
J
Fleddermann
Annelie
A
Pichert
Jürgen
J
Arnhold
D056649:Cathepsin G / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism*; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D053146:Myeloblastin / Q000378:metabolism*; D009504:Neutrophils / Q000201:enzymology* / Q000502:physiology; D010196:Pancreatic Elastase / Q000378:metabolism*
D008565:Membrane Proteins; D006493:Heparin; D056649:Cathepsin G; D010196:Pancreatic Elastase; D053146:Myeloblastin
Front Biosci (Landmark Ed). 2009 Jan 01;14:3409-18
19273284
J Clin Invest. 1998 Feb 15;101(4):890-8
9466984
J Biol Chem. 2009 Jul 24;284(30):19896-902
19447886
Nat Rev Immunol. 2006 Jul;6(7):541-50
16799473
J Mol Med (Berl). 2011 Jan;89(1):23-8
20809089
Autoimmun Rev. 2009 May;8(6):510-4
19185066
Curr Drug Targets Inflamm Allergy. 2005 Aug;4(4):447-54
16101521
J Biol Chem. 2008 Dec 19;283(51):35976-82
18854317
Cell Mol Life Sci. 2003 Dec;60(12):2575-85
14685684
Nat Rev Immunol. 2008 May;8(5):349-61
18437155
Microbes Infect. 2003 Nov;5(14):1317-27
14613775
Eur J Biochem. 1999 Apr;261(1):155-62
10103046
Lab Invest. 2002 May;82(5):521-33
12003992
J Biol Chem. 1991 Aug 15;266(23):15356-62
1869557
Protein Sci. 2009 Mar;18(3):579-94
19241385
Am J Pathol. 1990 Nov;137(5):1113-20
2240162
FEBS Lett. 1995 Oct 23;374(1):29-33
7589506
Am J Pathol. 2007 Jul;171(1):2-8
17591947
Clin Exp Immunol. 2010 Aug;161(2):389-96
20456416
Chest. 2006 Jun;129(6):1673-82
16778289
Apoptosis. 2006 Oct;11(10):1709-26
16951923
Arch Biochem Biophys. 1961 Nov;95:271-8
13890599
J Biol Chem. 2007 May 11;282(19):14645-54
17384412
J Biol Chem. 1994 Nov 25;269(47):29502-8
7961933
Mol Cell Proteomics. 2005 Oct;4(10):1503-21
15985654
FASEB J. 2006 Jan;20(1):9-22
16394262
Am J Respir Cell Mol Biol. 1999 Apr;20(4):729-36
10101005
Blood. 2007 Dec 1;110(12):4086-95
17712045
Biochimie. 2008 May;90(5):749-61
18261994
Am J Med Sci. 2001 Jan;321(1):33-41
11202478